Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengwei Wu

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
Nature Microbiology|April 22, 2024
Cerastecins inhibit membrane lipooligosaccharide transport in drug-resistant Acinetobacter baumanniiHao Wang, Andrii Ishchenko, Jason Skudlarek, et al.
Journal of Medicinal Chemistry|May 27, 2026
Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SARHubert Josien, Anilkumar G Nair, Fa-Xiang Ding, et al.
Journal of Medicinal Chemistry|August 22, 2024
Cerastecin Inhibition of the Lipooligosaccharide Transporter MsbA to Combat <i>Acinetobacter baumannii</i>: From Screening Impurity to <i>In Vivo</i> EfficacyJason W Skudlarek, Andrew J Cooke, Helen J Mitchell, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
Nature Microbiology|April 22, 2024
Cerastecins inhibit membrane lipooligosaccharide transport in drug-resistant Acinetobacter baumanniiHao Wang, Andrii Ishchenko, Jason Skudlarek, et al.
Journal of Medicinal Chemistry|May 27, 2026
Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SARHubert Josien, Anilkumar G Nair, Fa-Xiang Ding, et al.
Journal of Medicinal Chemistry|August 22, 2024
Cerastecin Inhibition of the Lipooligosaccharide Transporter MsbA to Combat <i>Acinetobacter baumannii</i>: From Screening Impurity to <i>In Vivo</i> EfficacyJason W Skudlarek, Andrew J Cooke, Helen J Mitchell, et al.
Pageof 14